BioSpace News Archive

Press Releases

MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results

February 22, 2026
·
24 min read
Press Releases

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting

February 22, 2026
·
2 min read
Press Releases

New England Biolabs® to present latest updates in Next Generation Sequencing Sample Preparation at 2026 AGBT Meeting

February 22, 2026
·
4 min read
Press Releases

Discovery Could Make Immune Checkpoint Inhibitors Safer

February 22, 2026
·
3 min read
Press Releases

New indication in pediatric patients, including term neonates for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) Injection

February 22, 2026
·
8 min read
Press Releases

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

February 22, 2026
·
9 min read
Press Releases

Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept

February 22, 2026
·
5 min read
Press Releases

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

February 22, 2026
·
8 min read
Press Releases

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 20, 2026

February 22, 2026
·
3 min read
Press Releases

FDA Clears FluoGuide’s IND for FG001 in High-Grade Glioma; U.S. Clinical Trial Remains on Track

February 22, 2026
·
3 min read